[Pharmacological studies on the diuretic action of azosemide [5-(4'-chloro-5'-sulfamoyl-2'-thenylamino)-phenyltetrazole], a new diuretic (3). Effect of azosemide following pretreatment with SA-446, an angiotensin I converting enzyme inhibitor, or propranolol, a beta-adrenergic blocker, in HgCl2-induced acute renal failure in rats].
D015097:3-Mercaptopropionic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*; D058186:Acute Kidney Injury / Q000139:chemically induced / Q000652:urine*; D000818:Animals; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D004232:Diuretics / Q000494:pharmacology*; D004357:Drug Synergism; D004573:Electrolytes / Q000652:urine*; D005665:Furosemide / Q000494:pharmacology; D008297:Male; D008627:Mercuric Chloride; D008628:Mercury; D009842:Oligopeptides / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D011458:Prostaglandins E / Q000652:urine; D051381:Rats; D011919:Rats, Inbred Strains; D013424:Sulfanilamides / Q000494:pharmacology*; D013438:Sulfhydryl Compounds; D013722:Teprotide; D053778:Thiazolidines; D013777:Tetrazoles; D013876:Thiophenes; D000096926:Benzenesulfonamides
D015097:3-Mercaptopropionic Acid; D003404:Creatinine; D004232:Diuretics; D004573:Electrolytes; D005665:Furosemide; D008627:Mercuric Chloride; D008628:Mercury; D009842:Oligopeptides; D011433:Propranolol; D011458:Prostaglandins E; D013424:Sulfanilamides; D013438:Sulfhydryl Compounds; D013722:Teprotide; D053778:Thiazolidines; C033437:rentiapril; C018222:azosemide; D013777:Tetrazoles; D013876:Thiophenes; D000096926:Benzenesulfonamides